E. Quoix

1.2k total citations
43 papers, 847 citations indexed

About

E. Quoix is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, E. Quoix has authored 43 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in E. Quoix's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (8 papers). E. Quoix is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (8 papers). E. Quoix collaborates with scholars based in France, United States and Netherlands. E. Quoix's co-authors include E Weitzenblum, Romain Kessler, Ari Chaouat, Monique Oswald–Mammosser, Catherine Charpentier, Bram Wieskopf, Christine Demangeat, Harvey Kreisman, R. Stenger and P. Gries and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and British Journal of Cancer.

In The Last Decade

E. Quoix

41 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Quoix France 11 631 292 136 136 86 43 847
M. Herbst Germany 12 466 0.7× 215 0.7× 95 0.7× 84 0.6× 51 0.6× 60 820
József Furák Hungary 14 331 0.5× 226 0.8× 154 1.1× 27 0.2× 52 0.6× 69 688
Pierre Ghosn Canada 6 328 0.5× 124 0.4× 120 0.9× 46 0.3× 48 0.6× 10 516
Luis F. Fajardo United States 8 237 0.4× 103 0.4× 67 0.5× 143 1.1× 125 1.5× 14 880
Morio Ohta Japan 9 598 0.9× 417 1.4× 135 1.0× 43 0.3× 56 0.7× 28 875
Lance Sieger United States 9 196 0.3× 166 0.6× 94 0.7× 60 0.4× 46 0.5× 16 545
Marcella Occelli Italy 15 176 0.3× 353 1.2× 141 1.0× 226 1.7× 35 0.4× 29 691
Yingyi Zhang China 10 155 0.2× 114 0.4× 117 0.9× 88 0.6× 41 0.5× 21 448
Seyoung Seo South Korea 15 294 0.5× 369 1.3× 217 1.6× 26 0.2× 43 0.5× 46 676
Claude Darte United States 9 219 0.3× 111 0.4× 115 0.8× 80 0.6× 19 0.2× 15 517

Countries citing papers authored by E. Quoix

Since Specialization
Citations

This map shows the geographic impact of E. Quoix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Quoix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Quoix more than expected).

Fields of papers citing papers by E. Quoix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Quoix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Quoix. The network helps show where E. Quoix may publish in the future.

Co-authorship network of co-authors of E. Quoix

This figure shows the co-authorship network connecting the top 25 collaborators of E. Quoix. A scholar is included among the top collaborators of E. Quoix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Quoix. E. Quoix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldini, Capucine, Étienne Brain, Siri Rostoft, et al.. (2021). 1827P European Society for Medical Oncology (ESMO)/International Society of Geriatric Oncology (SIOG) Joint Working Group (WG) survey on management of older patients with cancer. Annals of Oncology. 32. S1237–S1238. 3 indexed citations
2.
3.
Legrain, M, Éric Guérin, Thomas Lavaux, et al.. (2009). Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. British Journal of Cancer. 100(6). 985–992. 49 indexed citations
4.
Girard, Nicolas, Jean‐Yves Douillard, Nadine Bossard, et al.. (2009). Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. Lung Cancer. 69(1). 86–93. 54 indexed citations
5.
Beau‐Faller, Michèle, A. Neuville, Éric Guérin, et al.. (2009). EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. European Respiratory Journal. 33(2). 436–440. 36 indexed citations
6.
7.
Schmitz, Norbert, et al.. (2002). [Interstitial lung disease in a patient given gemcitabine].. PubMed. 58(1). 23–6. 4 indexed citations
8.
Bourjat, P, et al.. (2001). [Nasosinusal sarcoidosis: 13 cases].. PubMed. 118(4). 238–44. 1 indexed citations
9.
Gervais, R., E. Quoix, K. Mattson, et al.. (2000). Randomised Phase II study of topotecan/cisplatin versus topotecan/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC). Lung Cancer. 29(1). 50–50. 9 indexed citations
10.
Depierre, A, T. Le Chevalier, E. Quoix, et al.. (1997). 1 Phase II trial of navelbine (NVB), in small cell lung cancer (SCLC). Lung Cancer. 18. 3–3. 5 indexed citations
11.
Bardet, É., Jean‐Yves Douillard, A. Riviére, et al.. (1996). 2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial. International Journal of Radiation Oncology*Biology*Physics. 36(1). 345–346. 1 indexed citations
12.
Andrès, Emmanuel, et al.. (1995). [Curative antifungal treatment of invasive pulmonary aspergillosis].. PubMed. 51(4). 228–31. 2 indexed citations
13.
Oswald–Mammosser, Monique, E Weitzenblum, E. Quoix, et al.. (1995). Prognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy. CHEST Journal. 107(5). 1193–1198. 374 indexed citations
14.
Wieskopf, Bram, Christine Demangeat, Ashok Purohit, et al.. (1995). Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer. CHEST Journal. 108(1). 163–169. 122 indexed citations
15.
Depierre, A, B. Milleron, D Moro, et al.. (1995). 1053 Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S220–S220. 1 indexed citations
16.
Moro, D, P. Jacoulet, E. Quoix, et al.. (1994). Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue française.. PubMed. 14(1B). 301–4. 6 indexed citations
17.
Chevalier, Thierry Le, S. Gouva, E. Quoix, et al.. (1989). Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma. European Journal of Cancer and Clinical Oncology. 25(11). 1651–1652. 12 indexed citations
18.
Quoix, E., et al.. (1984). [Preliminary results concerning the value of chemotherapy in the treatment of inoperable bronchial carcinoma (excluding small-cell anaplastic carcinoma)].. PubMed. 40(2). 127–9. 1 indexed citations
19.
Seibert, Rachel, et al.. (1984). [Current review apropos of a case of unilateral agenesis of the pulmonary artery].. PubMed. 40(2). 135–8. 2 indexed citations
20.
Quoix, E., et al.. (1978). [Hereditary antithrombin III deficiency causing recurrent thrombo-embolic problems (author's transl)].. PubMed. 7(12). 999–1002. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Herbst Breakdown of academic impact, for papers by József Furák Breakdown of academic impact, for papers by Pierre Ghosn Breakdown of academic impact, for papers by Luis F. Fajardo Breakdown of academic impact, for papers by Morio Ohta Breakdown of academic impact, for papers by Lance Sieger Breakdown of academic impact, for papers by Marcella Occelli Breakdown of academic impact, for papers by Yingyi Zhang Breakdown of academic impact, for papers by Seyoung Seo Breakdown of academic impact, for papers by Claude Darte
Rankless by CCL
2026